HPLC analysis of raloxifene hydrochloride and its application to drug quality control studies

Pharmacological Research

Volumn 52, Issue 4, 2005, Pages 334-339

  Trontelj, Jurij ^a   Vovk, Tomaž ^a   Bogataj, Marija ^a   Mrhar, Aleš ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Coulometric detector; Dissolution; Drug quality control; HPLC; Raloxifene

Indexed keywords

EXCIPIENT; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ACCURACY; ARTICLE; CHEMICAL COMPOSITION; COULOMETRY; DISSOLUTION; DRUG DETERMINATION; DRUG QUALITY; DRUG SOLUBILITY; DRUG STABILITY; EXCIPIENT COMPATIBILITY; EXPERIMENT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; PROCESS DEVELOPMENT; QUALITY CONTROL; QUANTITATIVE ANALYSIS; SPECTROPHOTOMETER; TABLET; VALIDATION PROCESS;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; ESTROGEN ANTAGONISTS; QUALITY CONTROL; RALOXIFENE; REPRODUCIBILITY OF RESULTS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SOLUBILITY; TABLETS;

EID: 23844486002     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2005.05.007     Document Type: Article

References (14)

1. D. Hochner-Celnikier Pharmacokinetics of raloxifene and its clinical application Eur J Obstet Gynecol Reprod Biol 85 1 1999 23 29
2. C.R. Cummings, S. Eckert, K.A. Krueger, D. Grady, T.J. Powles, and J.A. Cauley Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. multiple outcomes of raloxifene evaluation (MORE) investigators JAMA 281 23 1999 2189 2197
3. M. Heringa Review on raloxifene: profile of a selective estrogen receptor modulator Int J Clin Pharmacol Ther 41 8 2003 331 345
4. Accessed April 2005: http://www.drugresourcecenter.com/evista/evista.htm
5. J.S. Teeter, and R.D. Meyerhoff Environ Toxicol Chem 21 4 2002 729 736
6. J. Zweigenbaum, and J. Henion Bioanalytical high-throughput selected reaction monitoring-LC/MS determination of selected estrogen receptor modulators in human plasma: 2000 samples/day Anal Chem 72 11 2000 2446 2454
7. Accessed March 2004: http://www.ukmi.nhs.uk/NewMaterial/html/docs/ raloxifene.pdf
8. D.C. Kemp, P.W. Fan, and J.C. Stevens Characterization of raloxifene glucuronidation in vitro: contribution of intestinal metabolism to presystemic clearance Drug Metab Dispos 30 6 2002 694 700
9. E.J. Jeong, L. Huimin, and M. Hu Disposition mechanisms of raloxifene in the human intestinal Caco-2 model J Pharmacol Exp Ther 310 1 2004 376 385
10. J. Dharuman, V. Ravichandran, N. Thirumoorthy, and A. Dharamasi Spectrophotometric analysis of raloxifene hydrochloride in pure and pharmaceutical formulations Pharmazie 59 9 2004 720 721
11. Scott RPW, Liquid Chromatography Detectors, part of the Chrom Ed Series, Laboratorytalk, Library4science.com © 2002-2003. http://www.laboratorytalk. com/books/chem/chrom/rs_5/rs_5_85.html (accessed April 2005).
12. J. Wittig, S. Wittemer, and M. Veit Validated method for the determination of hydroquinone in human urine by high-performance liquid chromatography-coulometric-array detection J Chromatogr B Biomed Sci Appl 761 1 2001 125 132
13. ICH-Q2B, Guidance for Industry: ICH-Q2B, Validation of Analytical Procedures: Methodology, Food and Drug Administration, Rockville, MD, 19 May; 1997.
14. V.P. Shah, K.K. Midha, S. Dighe, I.J. McGilveray, J.P. Skelly, and A. Yacobi Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies: Sponsored by the American Association of Pharmaceutical Chemists, U.S. Food and Drug Administration, Federation Internationale Pharmaceutique. Health Protection Branch (Canada) and Association of Official Analytical Chemists Int J Pharm 82 1-2 1992 1 7